200 related articles for article (PubMed ID: 27356668)
1. Decreasing the ratio of matriptase/HAI‑1 by downregulation of matriptase as a potential adjuvant therapy in ovarian cancer.
Sun P; Jiang Z; Chen X; Xue L; Mao X; Ruan G; Song Y; Mustea A
Mol Med Rep; 2016 Aug; 14(2):1465-74. PubMed ID: 27356668
[TBL] [Abstract][Full Text] [Related]
2. [Expression and significance of matriptase in ovarian cancer cells with diverse metastatic potential].
Jiang ZQ; Chen XF; Sun PM; Mao XD; Lin F; Song YY
Zhonghua Fu Chan Ke Za Zhi; 2013 May; 48(5):370-4. PubMed ID: 24016481
[TBL] [Abstract][Full Text] [Related]
3. [Impact of the biological function on epithelial ovarian cancer with ITIH4 gene expression down-regulating in vitro].
Huang M; Wang Q; Zhang W; Li DR; Li L
Zhonghua Fu Chan Ke Za Zhi; 2013 Jan; 48(1):34-40. PubMed ID: 23531249
[TBL] [Abstract][Full Text] [Related]
4. Over-expression of survivin is a factor responsible for differential responses of ovarian cancer cells to S-allylmercaptocysteine (SAMC).
Wu J; Zhao S; Zhang J; Qu X; Jiang S; Zhong Z; Zhang F; Wong Y; Chen H
Exp Mol Pathol; 2016 Apr; 100(2):294-302. PubMed ID: 26896649
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of microtubule-associated protein 1 light chain 3B via small-interfering RNA or 3-methyladenine impairs hypoxia-induced HO8910PM and HO8910 epithelial ovarian cancer cell migration and invasion and is associated with RhoA and alterations of the actin cytoskeleton.
Tang Z; Zhang N; Di W; Li W
Oncol Rep; 2015 Mar; 33(3):1411-7. PubMed ID: 25607473
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells.
Liu Y; Zheng D; Liu M; Bai J; Zhou X; Gong B; Lü J; Zhang Y; Huang H; Luo W; Huang G
Tumour Biol; 2015 Sep; 36(10):7997-8006. PubMed ID: 25967456
[TBL] [Abstract][Full Text] [Related]
7. Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters.
Oberst MD; Johnson MD; Dickson RB; Lin CY; Singh B; Stewart M; Williams A; al-Nafussi A; Smyth JF; Gabra H; Sellar GC
Clin Cancer Res; 2002 Apr; 8(4):1101-7. PubMed ID: 11948120
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between cathepsin L and invasion and metastasis of ovarian carcinoma cells].
Wang SM; Li L; Zhang W; Li DR; Tang BJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):598-602. PubMed ID: 21029616
[TBL] [Abstract][Full Text] [Related]
9. Matriptase activation of Gq drives epithelial disruption and inflammation via RSK and DUOX.
Ma J; Scott CA; Ho YN; Mahabaleshwar H; Marsay KS; Zhang C; Teow CK; Ng SS; Zhang W; Tergaonkar V; Partridge LJ; Roy S; Amaya E; Carney TJ
Elife; 2021 Jun; 10():. PubMed ID: 34165081
[TBL] [Abstract][Full Text] [Related]
10. Silencing of cyclooxygenase-2 inhibits the growth, invasion and migration of ovarian cancer cells.
Lin Y; Cui M; Xu T; Yu W; Zhang L
Mol Med Rep; 2014 Jun; 9(6):2499-504. PubMed ID: 24718658
[TBL] [Abstract][Full Text] [Related]
11. [Inhibitory effects of antisense Snail on invasion and migration of ovarian carcinoma cells].
Jin HY; Feng YJ
Zhonghua Fu Chan Ke Za Zhi; 2005 Jun; 40(6):400-3. PubMed ID: 16008892
[TBL] [Abstract][Full Text] [Related]
12. [Suppression of insulin-like growth factor-1 receptor by RNA interference inhibits cell growth in vitro and induces chemosensitization of HO8910PM cell to cisplatin].
Gao H; Shi J; Ge SF; DI W
Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):45-9. PubMed ID: 18366933
[TBL] [Abstract][Full Text] [Related]
13. Curcumin-targeting pericellular serine protease matriptase role in suppression of prostate cancer cell invasion, tumor growth, and metastasis.
Cheng TS; Chen WC; Lin YY; Tsai CH; Liao CI; Shyu HY; Ko CJ; Tzeng SF; Huang CY; Yang PC; Hsiao PW; Lee MS
Cancer Prev Res (Phila); 2013 May; 6(5):495-505. PubMed ID: 23466486
[TBL] [Abstract][Full Text] [Related]
14. TM4SF1 is a potential target for anti-invasion and metastasis in ovarian cancer.
Gao C; Yao H; Liu H; Feng Y; Yang Z
BMC Cancer; 2019 Mar; 19(1):237. PubMed ID: 30876464
[TBL] [Abstract][Full Text] [Related]
15. [Effect of semaphorin4D gene silencing on malignant behavior of human ovarian cancer SKOV3 cells].
Chen Y; Zhang L; Wu HJ; Liu WX; Hao Q
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):324-30. PubMed ID: 21875458
[TBL] [Abstract][Full Text] [Related]
16. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of small interfering RNA targeting insulin-like growth factor-I receptor in ovarian cancer OVCAR3 cells.
An Y; Cai Y; Guan Y; Cai L; Yang Y; Feng X; Zheng J
Cancer Biother Radiopharm; 2010 Oct; 25(5):545-52. PubMed ID: 20950153
[TBL] [Abstract][Full Text] [Related]
18. Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model.
Ye J; Kawaguchi M; Haruyama Y; Kanemaru A; Fukushima T; Yamamoto K; Lin CY; Kataoka H
Cancer Sci; 2014 Jan; 105(1):44-51. PubMed ID: 24147538
[TBL] [Abstract][Full Text] [Related]
19. Suppression of HER-2 via siRNA interference promotes apoptosis and decreases metastatic potential of SKOV‑3 human ovarian carcinoma cells.
Lu YM; Rong ML; Shang C; Wang N; Li X; Zhao YY; Zhang SL
Oncol Rep; 2013 Mar; 29(3):1133-9. PubMed ID: 23292493
[TBL] [Abstract][Full Text] [Related]
20. Cleavage of hepatocyte growth factor activator inhibitor-1 by membrane-type MMP-1 activates matriptase.
Domoto T; Takino T; Guo L; Sato H
Cancer Sci; 2012 Mar; 103(3):448-54. PubMed ID: 22118498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
